title: On the mechanisms of phenothiazine-induced mitochondrial permeability transition: Thiol oxidation, strict Ca2+ dependence, and cyt c release.
abstract: Phenothiazines (PTZ) are drugs widely used in the treatment of schizophrenia. Trifluoperazine, a piperazinic PTZ derivative, has been described as inhibitor of the mitochondrial permeability transition (MPT). We reported previously the antioxidant activity of thioridazine at relatively low concentrations associated to the inhibition of the MPT (Brit. J. Pharmacol., 2002;136:136-142). In this study, it was investigated the induction of MPT by PTZ derivatives at concentrations higher than 10 microM focusing on the molecular mechanism involved. PTZ promoted a dose-response mitochondrial swelling accompanied by mitochondrial transmembrane potential dissipation and calcium release, being thioridazine the most potent derivative. PTZ-induced MPT was partially inhibited by CsA or Mg(2+) and completely abolished by the abstraction of calcium. The oxidation of reduced thiol group of mitochondrial membrane proteins by PTZ was upstream the PTP opening and it was not sufficient to promote the opening of PTP that only occurred when calcium was present in the mitochondrial matrix. EPR experiments using DMPO as spin trapping excluded the participation of reactive oxygen species on the PTZ-induced MPT. Since PTZ give rise to cation radicals chemically by the action of peroxidases and cyanide inhibited the PTZ-induced swelling, we propose that PTZ bury in the inner mitochondrial membrane and the chemically generated PTZ cation radicals modify specific thiol groups that in the presence of Ca(2+) result in MPT associated to cytochrome c release. These findings contribute for the understanding of mechanisms of MPT induction and may have implications for the cell death induced by PTZ.
authors.affiliation: Centro Interdisciplinar de Investigação Bioquímica, Universidade de Mogi das Cruzes, Mogi das Cruzes, SP, Brazil.
authors.forename: Thiago S
authors.initials: TS
authors.lastname: Cruz
authors.forename: Priscila A
authors.initials: PA
authors.lastname: Faria
authors.forename: Débora P
authors.initials: DP
authors.lastname: Santana
authors.forename: Juliana C
authors.initials: JC
authors.lastname: Ferreira
authors.forename: Vitor
authors.initials: V
authors.lastname: Oliveira
authors.forename: Otaciro R
authors.initials: OR
authors.lastname: Nascimento
authors.forename: Giselle
authors.initials: G
authors.lastname: Cerchiaro
authors.forename: Carlos
authors.initials: C
authors.lastname: Curti
authors.forename: Iseli L
authors.initials: IL
authors.lastname: Nantes
authors.forename: Tiago
authors.initials: T
authors.lastname: Rodrigues
mesh_terms: D000818:Animals; D002118:Calcium / Q000378:metabolism*; D003486:Cyanides; D016572:Cyclosporine; D045304:Cytochromes c / Q000378:metabolism*; D008274:Magnesium; D053078:Membrane Potential, Mitochondrial / Q000187:drug effects; D008565:Membrane Proteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D051336:Mitochondrial Membranes / Q000187:drug effects* / Q000502:physiology; D015394:Molecular Structure; D010084:Oxidation-Reduction; D010539:Permeability; D010544:Peroxidases; D010640:Phenothiazines / Q000737:chemistry / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D013438:Sulfhydryl Compounds / Q000378:metabolism*
chemical_list: D003486:Cyanides; D008565:Membrane Proteins; D010640:Phenothiazines; D013438:Sulfhydryl Compounds; D016572:Cyclosporine; D045304:Cytochromes c; D010544:Peroxidases; D008274:Magnesium; D002118:Calcium